Raman Prakash (CIK 2018686) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-22). Recent activity: Buy BDTX (7,907 shares), Buy BDTX (6,105 shares), Buy BDTX (4,665 shares), Buy BDTX (3,843 shares), Buy BDTX (5,526 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 7,907 | $13,126 |
| 2026-03-20 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 6,105 | $13,126 |
| 2025-12-15 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 4,665 | $12,875 |
| 2025-09-22 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 3,843 | $12,874 |
| 2025-06-20 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 5,526 | $12,876 |
| 2025-03-21 | Black Diamond Therapeutics, Inc. (BDTX) | Director | Buy | 6,848 | $12,874 |
Source: SEC Form 4 filings · as of 2026-06-22